Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.05 USD
Change Today 0.00 / 0.00%
Volume 0.0
KLYG On Other Exchanges
As of 8:10 PM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

kelyniam global inc (KLYG) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/18/14 - $0.18
52 Week Low
07/21/15 - $0.04
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for KELYNIAM GLOBAL INC (KLYG)

Related News

No related news articles were found.

kelyniam global inc (KLYG) Related Businessweek News

No Related Businessweek News Found

kelyniam global inc (KLYG) Details

Kelyniam Global, Inc., a medical device manufacturing company, produces custom prosthetics utilizing computer aided design and computer aided manufacturing of medical grade polymers. The company offers cranial implants to replace damaged bone structures. The company was formerly known as Ketner Global Investments, Inc. and changed its name to Kelyniam Global, Inc. in December, 2007. Kelyniam Global, Inc. was founded in 2005 and is based in Canton, Connecticut.

kelyniam global inc (KLYG) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kelyniam global inc (KLYG) Key Developments

Kelyniam Global, Inc. Reports Sales Results for the Second and Third Quarter of 2014

Kelyniam Global, Inc. reported sales results for the second and third quarter of 2014. For the second quarter, the company reported sales of $436,865. For the third quarter, the company reported sales of $455,401.

Kelyniam Global, Inc. Announces Board Changes; Reports Earnings Results for the First Quarter of 2014

Kelyniam Global, Inc. announced that the board has appointed Dr. Mark Smith, a prominent Nuerosurgeon, and Dr. Naveh Levy, a practicing Diagnostic Radiologist, to the board of directors. Mark V Smith, M.D. is a neurosurgeon with over 20 years of clinical experience. The company reported earnings results for the first quarter of 2014. For the quarter, the company generated net income of $71,205. Compared with first quarter 2013, net sales increased 23% from $437,415 to $540,286, as a result of increased market penetration, gross profit moved up from $229,027 to $269,788, and net income swung from a loss of $17,272 to a profit of $71,205.

Kelyniam Global Inc. Reports Preliminary Revenues Results for the Year 2013

Kelyniam Global Inc. announced preliminary revenue of $1,857,516 for 2013. This represents an increase of 54% compared to sales of $1,206,227 in 2012.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KLYG:US $0.05 USD 0.00

KLYG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KLYG.
View Industry Companies

Industry Analysis


Industry Average

Valuation KLYG Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.6x
Price/Book 1.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KELYNIAM GLOBAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at